Access Bio Inc Korean Depository Receipts 950130
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $6,470.00
- Day Range
- $6,420.00–6,530.00
- 52-Week Range
- —–—
- Bid/Ask
- $6,440.00 / $6,450.00
- Market Cap
- $218.09 Bil
- Volume/Avg
- 73,298 / 1.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.16
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 0.90%
Company Profile
Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Growth
- Total Number of Employees
- 116
- Website
- https://www.accessbio.net
Valuation
|
Metric
|
950130
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.35 |
Price/Sales | 2.16 |
Price/Cash Flow | — |
Price/Earnings
950130
Financial Strength
|
Metric
|
950130
|
|---|---|
Quick Ratio | 9.86 |
Current Ratio | 11.32 |
Interest Coverage | −9.63 |
Quick Ratio
950130
Profitability
|
Metric
|
950130
|
|---|---|
Return on Assets (Normalized) | −3.35% |
Return on Equity (Normalized) | −3.97% |
Return on Invested Capital (Normalized) | −4.52% |
Return on Assets
950130
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Zxvkrqrgm | Stsj | $236.6 Bil | |||
| Danaher Corp
DHR
| Hpgdhqttg | Kqbxfy | $200.0 Bil | |||
| IQVIA Holdings Inc
IQV
| Mkmktxs | Xptqmxg | $43.1 Bil | |||
| Agilent Technologies Inc
A
| Cjkpjpgjfm | Bswk | $42.2 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Ytyjrhjc | Twd | $41.9 Bil | |||
| Mettler-Toledo International Inc
MTD
| Wwklwqwg | Fflwrn | $31.6 Bil | |||
| Icon PLC
ICLR
| Jvvgxyst | Scypmzs | $23.7 Bil | |||
| Waters Corp
WAT
| Tjrmmzlgz | Yqt | $21.1 Bil | |||
| Illumina Inc
ILMN
| Zswsplbdh | Hjzrbnx | $21.1 Bil | |||
| Labcorp Holdings Inc
LH
| Tlskfvcty | Bqhvn | $18.5 Bil |
United States